Teza Capital Management LLC Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Teza Capital Management LLC bought a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 44,496 shares of the company's stock, valued at approximately $1,032,000.

Other institutional investors also recently modified their holdings of the company. Wellington Management Group LLP lifted its holdings in Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after acquiring an additional 8,400,208 shares during the period. Norges Bank purchased a new stake in shares of Option Care Health during the 4th quarter valued at $60,219,000. Freestone Grove Partners LP bought a new stake in shares of Option Care Health during the 4th quarter worth $17,487,000. Dimensional Fund Advisors LP boosted its holdings in shares of Option Care Health by 17.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after buying an additional 591,042 shares during the last quarter. Finally, Victory Capital Management Inc. grew its position in Option Care Health by 31.1% during the fourth quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock valued at $49,310,000 after buying an additional 503,840 shares during the period. 98.05% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities reissued a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. Barrington Research reissued an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 30th. Finally, Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and upped their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, Option Care Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.

Option Care Health Stock Performance

Option Care Health stock traded down $0.68 during mid-day trading on Thursday, reaching $32.03. The company's stock had a trading volume of 1,110,277 shares, compared to its average volume of 1,856,115. The firm's fifty day moving average price is $33.09 and its two-hundred day moving average price is $29.17. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a market capitalization of $5.24 billion, a P/E ratio of 26.92, a PEG ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm's quarterly revenue was up 16.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.26 earnings per share. Sell-side analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insider Buying and Selling at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This represents a 40.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.64% of the company's stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.